Talis Biomedical Ownership 2024 | Who Owns Talis Biomedical Now?
Institutional Ownership
0.83%
Insider Ownership
8.31%
Retail Ownership
90.86%
Institutional Holders
20.00
Talis Biomedical Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | - | - | - | -174 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -27,860 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -61,857 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -45,294 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -140,530 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -76,307 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -49,007 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -273 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -26 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,564 | -100.00% | - | Sep 30, 2023 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -200 | -100.00% | - | Sep 30, 2023 |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | - | - | - | -10 | -100.00% | - | Sep 30, 2023 |
Talis Biomedical's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | - | - | - | -174 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -27,860 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -61,857 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -45,294 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -140,530 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -76,307 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -49,007 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -273 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -26 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,564 | -100.00% | - | Sep 30, 2023 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -200 | -100.00% | - | Sep 30, 2023 |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | - | - | - | -10 | -100.00% | - | Sep 30, 2023 |
The largest Talis Biomedical shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Talis Biomedical (TLIS), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | - | - | - | -10 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -26 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -174 | -100.00% | - | Sep 30, 2023 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -200 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -273 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,564 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -27,860 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -45,294 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -49,007 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -61,857 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -76,307 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -140,530 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Talis Biomedical's largest institutional buyer is NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC. The company purchased -10.00 stocks of TLIS, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -140,530 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -76,307 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -61,857 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -49,007 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -45,294 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -27,860 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,564 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -273 | -100.00% | - | Sep 30, 2023 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -200 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -174 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -26 | -100.00% | - | Sep 30, 2023 |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | - | - | - | -10 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Talis Biomedical's biggest institutional seller is GEODE CAPITAL MANAGEMENT, LLC. The company sold -0.14M shares of TLIS, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -140,530 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -76,307 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -61,857 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -49,007 | -100.00% | - | Sep 30, 2023 |
| DEUTSCHE BANK AG\ | - | - | - | -45,294 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -27,860 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,564 | -100.00% | - | Sep 30, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -273 | -100.00% | - | Sep 30, 2023 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -200 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -174 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -26 | -100.00% | - | Sep 30, 2023 |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | - | - | - | -10 | -100.00% | - | Sep 30, 2023 |
Talis Biomedical's largest sold out institutional shareholder by shares sold is GEODE CAPITAL MANAGEMENT, LLC, sold -0.14M shares, valued at -, as of undefined.
Talis Biomedical Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| MERIDIAN FUND INC | 0.21% | 499,461 | - | - | Mar 28, 2024 |
| Humankind Benefit Corp | 0.06% | 1,366 | - | - | Dec 31, 2023 |
| VANGUARD EXPLORER FUND | 0.02% | 305,550 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 54,000 | - | - | Mar 28, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 28,827 | - | - | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.01% | 27,143 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,153 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 18,330 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 105,842 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 460,776 | - | - | Mar 31, 2024 |
| ETF Managers Trust | 0.00% | 7,979 | - | - | Dec 31, 2023 |
| Federated Hermes Equity Funds | 0.00% | 15,000 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 31,324 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 135,625 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 48,683 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,077 | - | - | Mar 31, 2024 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 10,370 | - | - | Feb 29, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 2,734 | - | - | Mar 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 5,090 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 5,042 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 416 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 4,728 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 167,330 | - | - | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 65,216 | - | - | Feb 29, 2024 |
| Global X Funds | 0.00% | 4,103 | - | - | Jan 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 4,159 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 31,013 | -12,746 | -29.13% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 300 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 696 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 11,497 | 558 | 5.10% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 7,573 | - | - | Mar 28, 2024 |
| SEASONS SERIES TRUST | 0.00% | 1,279 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 3,300 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 897 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 136 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 33,391 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 81,687 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 316 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 102,232 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 47,944 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 600 | - | - | Mar 28, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 21,055 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 78 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 5,490 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 86 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 916 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,886 | - | - | Mar 31, 2024 |
| BLACKROCK LARGE CAP SERIES FUNDS, INC. | 0.00% | 623 | -69 | -9.97% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 15 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 32,338 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,317 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,143 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,338 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 112 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 529 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 12,060 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,634 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 8,168 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 6,900 | - | - | Mar 28, 2024 |
| Investment Managers Series Trust | 0.00% | 2,889 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 100 | - | - | Mar 31, 2023 |
| Bridge Builder Trust | 0.00% | 5,378 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 24,279 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,170 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 5 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,229 | - | - | Mar 28, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 773 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,225 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,228 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 2,185 | - | - | Feb 29, 2024 |
Talis Biomedical's largest mutual fund holder by % of total assets is "MERIDIAN FUND INC", owning 499.46K shares, compromising 0.21% of its total assets.
Talis Biomedical Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 23 | 20 | - |
| 31 Mar, 23 | 20 | -20.00% |
| 31 Dec, 22 | 25 | 13.64% |
| 30 Sep, 22 | 22 | -15.38% |
| 30 Jun, 22 | 26 | -39.53% |
| 31 Mar, 22 | 43 | -8.51% |
| 31 Dec, 21 | 47 | 9.30% |
| 30 Sep, 21 | 43 | -2.27% |
| 30 Jun, 21 | 44 | -2.22% |
| 31 Mar, 21 | 45 | - |
As of 30 Jun 23, 20 institutions are holding Talis Biomedical's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 23 | 3,348,372 | -71.52% |
| 31 Mar, 23 | 11,758,102 | -6.52% |
| 31 Dec, 22 | 12,577,892 | -0.25% |
| 30 Sep, 22 | 12,609,237 | -15.44% |
| 30 Jun, 22 | 14,911,197 | -10.97% |
| 31 Mar, 22 | 16,748,283 | -4.32% |
| 31 Dec, 21 | 17,503,843 | -8.16% |
| 30 Sep, 21 | 19,059,034 | -2.71% |
| 30 Jun, 21 | 19,590,555 | -6.40% |
| 31 Mar, 21 | 20,930,988 | - |
Talis Biomedical (TLIS) has 3.35M shares outstanding as of 30 Jun 23, down -71.52% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 23 | 0.83% | 0.04% |
| 31 Mar, 23 | 43.85% | 1.99% |
| 31 Dec, 22 | 46.94% | 2.10% |
| 30 Sep, 22 | 47.32% | 1.51% |
| 30 Jun, 22 | 56.02% | 1.40% |
| 31 Mar, 22 | 63.28% | 1.06% |
| 31 Dec, 21 | 77.26% | 1.41% |
| 30 Sep, 21 | 73.91% | 1.27% |
| 30 Jun, 21 | 76.38% | 0.30% |
| 31 Mar, 21 | 159.65% | - |
As of 30 Jun 23, Talis Biomedical is held by 0.83% institutional shareholders, representing a 0.04% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 7 | 40.00% |
| 31 Mar, 23 | 5 | -54.55% |
| 31 Dec, 22 | 11 | 175.00% |
| 30 Sep, 22 | 4 | -66.67% |
| 30 Jun, 22 | 12 | -20.00% |
| 31 Mar, 22 | 15 | -28.57% |
| 31 Dec, 21 | 21 | -19.23% |
| 30 Sep, 21 | 26 | 36.84% |
| 30 Jun, 21 | 19 | -57.78% |
| 31 Mar, 21 | 45 | - |
7 institutional shareholders have increased their position in TLIS stock as of 30 Jun 23 compared to 5 in the previous quarter (a 40.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 6 | 20.00% |
| 31 Mar, 23 | 5 | -16.67% |
| 31 Dec, 22 | 6 | -33.33% |
| 30 Sep, 22 | 9 | -10.00% |
| 30 Jun, 22 | 10 | -56.52% |
| 31 Mar, 22 | 23 | 27.78% |
| 31 Dec, 21 | 18 | 125.00% |
| 30 Sep, 21 | 8 | -52.94% |
| 30 Jun, 21 | 17 | - |
| 31 Mar, 21 | - | - |
6 institutional shareholders have reduced their position in TLIS stock as of 30 Jun 23 compared to 5 in the previous quarter (a 20.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 23 | 20 | - | 3,348,372 | -71.52% | 0.83% | 0.04% | 7 | 40.00% | 6 | 20.00% |
| 31 Mar, 23 | 20 | -20.00% | 11,758,102 | -6.52% | 43.85% | 1.99% | 5 | -54.55% | 5 | -16.67% |
| 31 Dec, 22 | 25 | 13.64% | 12,577,892 | -0.25% | 46.94% | 2.10% | 11 | 175.00% | 6 | -33.33% |
| 30 Sep, 22 | 22 | -15.38% | 12,609,237 | -15.44% | 47.32% | 1.51% | 4 | -66.67% | 9 | -10.00% |
| 30 Jun, 22 | 26 | -39.53% | 14,911,197 | -10.97% | 56.02% | 1.40% | 12 | -20.00% | 10 | -56.52% |
| 31 Mar, 22 | 43 | -8.51% | 16,748,283 | -4.32% | 63.28% | 1.06% | 15 | -28.57% | 23 | 27.78% |
| 31 Dec, 21 | 47 | 9.30% | 17,503,843 | -8.16% | 77.26% | 1.41% | 21 | -19.23% | 18 | 125.00% |
| 30 Sep, 21 | 43 | -2.27% | 19,059,034 | -2.71% | 73.91% | 1.27% | 26 | 36.84% | 8 | -52.94% |
| 30 Jun, 21 | 44 | -2.22% | 19,590,555 | -6.40% | 76.38% | 0.30% | 19 | -57.78% | 17 | - |
| 31 Mar, 21 | 45 | - | 20,930,988 | - | 159.65% | - | 45 | - | - | - |
Talis Biomedical Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Talis Biomedical's stock was made by Markovich Rebecca on Apr 25 2023, selling 79,000 shares at $2.14 per share (valued at $169.06K).
Talis Biomedical Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 10 | 3 | 333.33% |
| Q1 2023 | - | - | - |
| Q2 2022 | 12 | - | - |
| Q4 2021 | 7 | - | - |
| Q3 2021 | 3 | 2 | 150.00% |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 30 | 37 | 81.08% |
| Q4 2020 | 2 | - | - |
0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Talis Biomedical's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 9 | - | - |
| Q4 2020 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Talis Biomedical's stocks.
Talis Biomedical Peer Ownership
| Ticker | Company |
|---|---|
| INVO | INVO Bioscience, Inc. |
| SGHT | Sight Sciences, Inc. |
| SSKN | STRATA Skin Sciences, Inc. |
| TIVC | Tivic Health Systems, Inc. |
| VAPO | Vapotherm, Inc. |
| NUWE | Nuwellis, Inc. |
| NPCE | NeuroPace, Inc. |
| BVS | Bioventus Inc. |
| BBLG | Bone Biologics Corporation |
| BJDX | Bluejay Diagnostics, Inc. |
| HSCS | Heart Test Laboratories, Inc. |
| MOTS | Motus GI Holdings, Inc. |
| TNON | Tenon Medical, Inc. |
TLIS Ownership FAQ
Who Owns Talis Biomedical?
Talis Biomedical is owned by institutional shareholders (0.83%), insiders (8.31%), and public (90.86%). The largest institutional shareholder of Talis Biomedical is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is MERIDIAN FUND INC (0.21% of total shares).
Who are the major institutional shareholders of Talis Biomedical?
Talis Biomedical's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, MORGAN STANLEY, DEUTSCHE BANK AG\, and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Talis Biomedical shareholders are there?
As of Jun 2023, there are 20 institutional shareholders of Talis Biomedical.
What percentage of Talis Biomedical is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN owns 0 shares of Talis Biomedical, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).
What percentage of Talis Biomedical is owned by NORTHERN TRUST CORP?
As of Sep 2023, NORTHERN TRUST CORP holds 0 shares of Talis Biomedical (TLIS), compromising 0% of the company, valued at $0.
What percentage of Talis Biomedical is owned by MORGAN STANLEY?
MORGAN STANLEY is the third largest holder of Talis Biomedical. The company owns 0 of the company's shares outstanding (worth $0).